A risk predictor of restenosis after superficial femoral artery stent implantation: relevance of mean platelet volume

Table 3 Comparison of blood parameters between two groups preoperative

	Total, n = 173	Restenosis, N = 34	No restenosis, n = 139	P value
Erythrocytic,× 10¹²/L	4.52 ± 0.57	4.47 ± 0.53	4.53 ± 0.59	0.57
Hemoglobin, g/L	141.4 ± 13.6	138.23 ± 15.07	142.25 ± 13.19	0.12
Leukocyte,× 10⁹/L	8.31 ± 2.88	7.64 ± 1.66	8.48 ± 3.09	0.12
Neutrophil,× 10⁹/L	5.71 ± 2.81	4.82 ± 1.35	5.93 ± 3.03	0.04
Neutrophil ratio,%	66.88 ± 10.5	62.84 ± 8.81	67.87 ± 10.79	0.01
Lymphocyte,× 10⁹/L	1.88 ± 0.70	2.01 ± 0.66	1.85 ± 0.71	0.24
Lymphocyte ratio,%	24.10 ± 8.53	26.86 ± 8.26	23.42 ± 8.49	0.03
NLR	3.84 ± 0.85	2.84 ± 0.36	4.09 ± 0.43	0.02
Eosinophil,× 10⁹/L	0.18 ± 0.18	0.18 ± 0.14	0.18 ± 0.1	0.84
Eosinophil ratio,%	2.39 ± 2.13	2.36 ± 1.63	2.39 ± 2.34	0.93
Basophils,× 10⁹/L	0.03 ± 0.02	0.03 ± 0.01	0.03 ± 0.02	0.77
Basophils ratio,%	0.47 ± 0.23	0.51 ± 0.17	0.46 ± 0.25	0.31
PDW,%	16.76 ± 1.03	16.95 ± 0.66	16.71 ± 1.10	0.23
Platelet,× 10⁹/L	231.3 ± 86.7	204.31 ± 51.23	237.99 ± 92.37	0.04
MPV, fL	8.34 ± 0.83	8.49 ± 0.91	8.31 ± 0.82	0.24

Key: PDW platelet distribution width, MPV mean platelet volume, NLR neutrophil–lymphocyte ratio

ISSN: 1471-2261